ホーム>>N-terminally acetylated Leu-enkephalin (Ac-L-Tyr-Gly-Gly-L-Phe-D-Leu-COOH)

N-terminally acetylated Leu-enkephalin (Ac-L-Tyr-Gly-Gly-L-Phe-D-Leu-COOH)

カタログ番号GC34399

Products are for research use only. Not for human use. We do not sell to patients.

N-terminally acetylated Leu-enkephalin (Ac-L-Tyr-Gly-Gly-L-Phe-D-Leu-COOH) 化学構造

サイズ 価格 在庫数 個数
1mg
$101.00
在庫あり
5mg
$202.00
在庫あり
10mg
$321.00
在庫あり
25mg
$689.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-terminally acetylated Leu-enkephalin is the N-terminally acetylated form of Leu-enkephalin. Leu-enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors.

Enkephalins (met- , leu-enkephalin, and enkephalin 8) and dynorphins are two classes of opioid peptides found in the spinal dorsal horn. Mu, delta, and kappa are three major subtypes of opioid receptors. Enkephalins are putative endogenous ligands for delta opioid receptors, and dynorphins are endogenous ligands for the kappa opioid receptors. Three receptor types resembling the vertebrate δ- and κ-type opioid receptors have been characterized pharmacologically in nervous tissues (e.g. Ki=18.9 nM for Leu-enkephalin) and localized by autoradiography at CHH terminals in the SG of C. maenas[1].

[1]. Leu-enkephalin is a five amino acid endogenous peptide that acts as an agonist at opioid receptors.

レビュー

Review for N-terminally acetylated Leu-enkephalin (Ac-L-Tyr-Gly-Gly-L-Phe-D-Leu-COOH)

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-terminally acetylated Leu-enkephalin (Ac-L-Tyr-Gly-Gly-L-Phe-D-Leu-COOH)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.